The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles
Abstract
Curcumin, the active ingredient of the rhizome curcuma longa has been extensively studied as an anticancer agent for various types of tumours. However, its efficacy as an anticancer agent is restricted due to poor absorption from the gastrointestinal tract, rapid metabolism and degradation in acidic medium. In the present study, we encapsulated curcumin in chitosan-pectinate nanoparticulate system (CUR-CS-PEC-NPs) for deployment of curcumin to the colon, whereby curcumin is protected against degradative effects in the upper digestive tract, and hence, maintaining its anticancer properties until colon arrival. The CUR-CS-PEC-NPs was taken up by HT-29 colorectal cancer cells which ultimately resulted in a significant reduction in cancer cell propagation. The anti-proliferative effect of the encapsulated curcumin was similar to that of free curcumin at equivalent doses which confirms that the encapsulation process did not impede the anticancer activity of curcumin. The oral bioavailability (C max , and AUC) of curcumin in CUR-CS-PEC-NPs was enhanced significantly by 4-folds after 6 hours of treatment compared to free curcumin. Furthermore, the clearance of curcumin from the CUR-CS-PEC-NPs was lower compared to free curcumin. These findings point to the potential application of the CUR-CS-PEC-NPs in the oral delivery of curcumin in the treatment of colon cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Modified chitosan derivatives also facilitated CRC targeting through strengthening the protection of encapsulant against acidic and enzyme degradation of gastrointestinal track (GIT).”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [42]
In the citing paper
“These chitosan modifications also facilitate in drug delivery to the colon, where therapeutic agents need to be protected from acidic pH of the stomach and enzymes degradation with minimal drug lose until they reach the colon.41,42”
From Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment (2022) · cites this paper as [42]
Citations
Cites
Pectin Matrix as Oral Drug Delivery Vehicle for Colon Cancer Treatment
Wong, T. W., Colombo, G., & Sonvico, F. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9564-z · Cited by 210
Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications
Udompornmongkol, P., & Chiang, B.-H. (2015) · Journal of Biomaterials Applications · doi:10.1177/0885328215594479 · Cited by 101
Research works printed but not linked: 49
- Milsom JW, 1998, Elsevier Sci. Inc, 187, 46
- 10.1200/JCO.2005.02.9017 · DOI
- 10.1002/bjs.10327 · DOI
- Miskovitz P, 2010, The Doctor’s Guide to Gastrointestinal Health
- Wu T, 2005, Cochrane Database Syst. Rev, 1
- 10.1093/annonc/mdg500 · DOI
- 10.1046/j.1365-2168.2002.02148.x · DOI
- 10.1016/S0002-9343(97)00397-5 · DOI
- 10.1634/theoncologist.9-1-80 · DOI
- Steinhauser EV, 2015, Turmeric curcumin: Discover the amazing health benefits and healing power of turmeric curcumin
- Wattenberg L, 1992, Cancer Chemoprevention
- Ravindran PN, 2007, Turmeric: The genus Curcuma, 10.1201/9781420006322 · DOI
- Braun L, 2010, Herbs and natural supplements inkling: An evidence-based guide
- 10.1016/j.ijpharm.2008.12.009 · DOI
- 10.1002/mnfr.201300724 · DOI
- 10.1016/j.colsurfb.2012.06.024 · DOI
- 10.1016/j.ejps.2013.08.036 · DOI
- 10.1007/s12033-009-9161-0 · DOI
- 10.1023/A:1011929016601 · DOI
- Paul S, 2014, Asian J Pharm Clin Res, 7, 201
- 10.1016/S1461-5347(98)00059-5 · DOI
- 10.1016/S0168-3659(03)00126-3 · DOI
- 10.1016/j.colsurfb.2014.01.007 · DOI
- 10.3109/10837450.2011.640688 · DOI
- Wang JJ, 2011, Int J Nanomed, 6, 765
- 10.1016/j.carbpol.2011.05.065 · DOI
- Srivastava P, 2015, Ind J Nat Product Res, 2, 10
- Philip AK, 2010, Int J Pharm Stud Res
- 10.1016/j.carbpol.2010.02.016 · DOI
- 10.1016/S0142-9612(03)00213-8 · DOI
- 10.1007/s10570-006-9095-7 · DOI
- 10.1208/s12249-016-0623-y · DOI
- 10.1073/pnas.76.3.1438 · DOI
- 10.1083/jcb.113.1.173 · DOI
- Aggarwal BB, Bhatt ID, Ichikawa H. 10 Curcumin — Biological and medicinal properties. Turmeric; the genus Curcuma. New York: Taylor & Francis; 2006; p.297–368.
- 10.1016/S0959-8049(00)00200-8 · DOI
- 10.1158/1535-7163.MCT-11-0391 · DOI
- 10.1111/j.1582-4934.2011.01292.x · DOI
- 10.1016/j.bbagen.2014.01.016 · DOI
- 10.1016/j.carbpol.2010.08.008 · DOI
- 10.1016/j.bbagen.2007.11.016 · DOI
- 10.1016/j.biomaterials.2010.04.062 · DOI
- 10.1016/j.jconrel.2009.01.018 · DOI
- 10.1016/j.nano.2009.04.001 · DOI
- 10.1016/j.jphotochemrev.2009.05.001 · DOI
- 10.1016/S1872-2040(07)60015-2 · DOI
- 10.1016/j.ejpb.2012.08.010 · DOI
- Aseh A, 2009, Int J Nanomed, 4, 115
- 10.1007/s11051-013-1893-x · DOI
Cited by
Sorted by citations
Current Advances in Chitosan Nanoparticles Based Oral Drug Delivery for Colorectal Cancer Treatment
Choukaife, H., Seyam, S., Alallam, B., Doolaanea, A. A., & Alfatama, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375229 · Cited by 127
Metadata
- Authors
- Alkhader, E., Roberts, C. J., Rosli, R., Yuen, K. H., Seow, E. K., Lee, Y. Z., & Billa, N.
- Venue
- Journal of Biomaterials Science, Polymer Edition
- Publisher
- Informa UK Limited
- Published
- 2018-12-12
- Volume
- 29
- Issue
- 18
- Pages
- 2281-2298
- ISSN
- 0920-5063
- 1568-5624
- Cited by
- 53
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles. https://app.cochat.ai/papers/10.1080/09205063.2018.1541500
- The paper
- Alkhader, E., Roberts, C. J., Rosli, R., Yuen, K. H., Seow, E. K., Lee, Y. Z., & Billa, N. (2018). Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles. Journal of Biomaterials Science, Polymer Edition. https://doi.org/10.1080/09205063.2018.1541500